NCT01816256View on ClinicalTrials.gov

Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 11, 2019

Study Completion Date

March 11, 2019

Conditions
Myeloproliferative Neoplasms (MPN)Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)
Interventions
PROCEDURE

Upper gastrointestinal endoscopy and Doppler ultrasound

This is a one arm study. All patients will receive two screening tests (Doppler ultrasound, upper gastrointestinal endoscopy).

Trial Locations (2)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 2M9

Princess Margaret Cancer Centre, Toronto

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University Health Network, Toronto

OTHER